Rhodium(<scp>iii</scp>) complexes with isoquinoline derivatives as potential anticancer agents: <i>in vitro</i> and <i>in vivo</i> activity studies

Taj-Malook Khan, Noor Shad Gul, Xing Lü, Rajesh Kumar, M. Iqbal Choudhary, Hong Liang, Zhen‐Feng Chen

Dalton Transactions · 2019 · 43 citations · 55 references

Concepts

Abstract

and released cytochrome C which ultimately activated caspases and the apoptosis pathway. The different biological activities of Rh1 and Rh2 could be associated with the presence of methoxy substituents on the ligands. In vivo studies showed that Rh1 effectively inhibited tumor growth in a T-24 xenograft mouse model with a less adverse effect than cisplatin. Overall, Rh1 and Rh2 induced apoptosis via mitochondrial pathways and could be developed as effective anticancer agents.

References

55